Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

Journal of Psychiatric Research

Volumn 34, Issue 3, 2000, Pages 171-181

  Zobel, Astrid W ^a   Nickel, Thomas ^a   Künzel, Heike E ^a   Ackl, Nibal ^a   Sonntag, Annette ^a   Ising, Marcus ^a   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; HYDROCORTISONE; UNCLASSIFIED DRUG;

ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; DRUG SAFETY; DRUG TOLERABILITY; ENDOCRINE FUNCTION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

EID: 0034193881     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(00)00016-9     Document Type: Article

References (41)

1. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., De Souza E.B. Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17:1996;166-172.
2. Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. USA. 90:1993;8967-8971.
3. Coplan J.D., Andrews M.W., Rosenblum L.A., Owens M.J., Friedman S., Gorman J.M., Nemeroff C.B. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. USA. 93:1996;1619-1623.
4. Davis M. The role of the amygdala in fear and axiety. Ann. Rev. Neurosci. 15:1992;353-375.
5. De Goeij D.C.E., Kvetnansky R., Whitnall M.H., Jezova D., Berkenbosch F., Tilders F.J.H. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology. 53:1991;150-159.
6. Gold P.W., Chrousos G., Kellner C., Post R., Roy A., Augerionos P., Schulte H., Oldfield E., Loriaux D.I. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am. J. Psychiatry. 14:1984;619-627.
7. 1 receptor antagonists: characterization and clinical application. Neuroendocrine workshop on stress sponsored by the Am. Neuroendocrine Soc.: June 21-23, 1998, New Orleans, LA. 1998;36.
8. 2 receptors mediate anxiogenic-like behavior. Regul. Peptides. 71:1997;15-21.
9. Holsboer F. Neuroendocrinology of mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology: The fourth generation of progress. 1995;957-969 Raven Press, New York.
10. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiat. Res. 33:1999;181-214.
11. Holsboer F., Barden N. Antidepressants and HPA regulation. Endocrine Rev. 17:1996;187-205.
12. Holsboer F., von Bardeleben U., Gerken A., Stalla G.K., Müller O.A. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N. Engl. J. Med. 311:1984;1127.
13. Holsboer F., Gerken A., von Bardeleben U., Grimm W., Beyer H., Müller O.A., Stalla G.K. Human corticotropin-releasing hormone in depression. Biol. Psychiatry. 21:1986;601-611.
14. Holsboer F., Spengler D., Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog. Brain Res. 93:1992;385-417.
15. Kalin N.H. Biological effects of corticotropin-releasing hormone administered to rhesus monkeys. Fed. Proc. 44:1985;249-253.
16. Keck FE, Holsboer F (2000): Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides (In press).
17. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Peptides. 59:1995;220-239.
18. Liebsch G., Montkowski A., Holsboer F., Landgraf R. Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour. Behav. Brain Res. 94:1998;301-310.
19. 2 receptor antisense oligonucleotides into the rat brain. J. Psychiat. Res. 33:1999;153-163.
20. Malkoski S.P., Dorin R.I. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol. Endocrinol. 13:1999;1629-1644.
21. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson E., Eklund K., Kilts D.C., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
22. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry. 45:1988;577-579.
23. Owens M.J., Nemeroff C.B. The physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43:1991;425-473.
24. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: a view from the portal. J. Neuroendocrinol. 3:1991;1-9.
25. Potter E., Sutton S., Conaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA. 91:1994;8777-8781.
26. Raadsheer F.C., Hoogendijk W.J.G., Stam F.C., Tilders F.J.H., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;433-436.
27. Sánchez M.M., Young L.J., Plotsky P.M., Insel T.R. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J. Comp. Neurol. 408:1999;365-377.
28. Schulkin J., Gold P.W., McEwen B.S. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology. 23:1998;219-243.
29. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley 3rd F.D., Winston E.N., Chen Y.L., Heym J. CP-154.526: A potent and selective nonpeptide antagonist of corticotropin-releasing factor receptors. Proc. Natl. Acad. Sci. USA. 93:1996;10477-10482.
30. 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroine-trained rats. Psychopharmacology. 137:1998;184-190.
31. Skutella T., Probst J.C., Criswell H., Moy C., Breese G., Jirikowski G.F., Holsboer F. Antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA reduces anxiety in shuttlebox performance. Neuroreport. 5:1994;2181-2185.
32. Skutella T., Probst J.C., Renner U., Holsboer F., Behl C. Corticotropin-releasing hormone receptor (type 1) antisense targeting reduces anxiety. Neuroscience. 85:1998;795-805.
33. Smith G.W., Aubry J.-M., Dellu F., Contarino A., Bilezikjian I.M., Gold L.H., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.-F. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 20:1998;1093-1102.
34. Steckler T., Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biological Psychiatry. 46:1999;1480-1508.
35. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14:1994;2579-2584.
36. Swanson L.W., Simmons D.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the parventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 285:1989;415-435.
37. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M.H.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., Wurst W. Impaired stress response and rduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet. 19:1998;162-166.
38. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science. 213:1981;1394-1397.
39. Valentino R.J., Foote S.L., Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann. NY Acad. Sci. 697:1993;173-188.
40. Webster E.L., Lewis D.B., Torpy D.J., Zachman E.K., Rice K.C., Chrousos G.P. In vivo and in vitro characterization of antalarmin, a non-peptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology. 137:1996;5747-5750.
41. Wotjak C.T., Kubota M., Liebsch G., Montkowski A., Holsboer F., Neumann I., Landgraf R. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion? J. Neuroscience. 16:1996;7725-7732.